Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,721 to 1,740 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Prognostic Value and Immune Landscapes of a m6A/m5C/m1A-Related LncRNAs Signature in Head and Neck Squamous Cell Carcinoma. | Front Cell Dev Biol | 2021 | 34917609 | PubTator, text mining | PubMed |
| Evaluation of Colocasia esculenta Schott in anti-cancerous properties with proximity extension assays. | Food Nutr Res | 2021 | 34908921 | PubTator, text mining | PubMed |
| Development of an Oxidative Phosphorylation-Related and Immune Microenvironment Prognostic Signature in Uterine Corpus Endometrial Carcinoma. | Front Cell Dev Biol | 2021 | 34901000 | PubTator, text mining | PubMed |
| Immunotherapy of Ovarian Cancer with Particular Emphasis on the PD-1/PDL-1 as Target Points. | Cancers (Basel) | 2021 | 34885169 | PubTator, text mining | PubMed |
| Vaccine-Based Immunotherapy for Head and Neck Cancers. | Cancers (Basel) | 2021 | 34885150 | PubTator, text mining | PubMed |
| Organ Specific Copy Number Variations in Visceral Metastases of Human Melanoma. | Cancers (Basel) | 2021 | 34885093 | PubTator, text mining | PubMed |
| Gp-100 as a Novel Therapeutic Target in Uveal Melanoma. | Cancers (Basel) | 2021 | 34885078 | PubTator, text mining | PubMed |
| Genetically Modified Cellular Therapies for Malignant Gliomas. | Int J Mol Sci | 2021 | 34884607 | PubTator, text mining | PubMed |
| Hypomethylation-driven AKT Serine/Threonine Kinase 3 promotes testicular germ cell tumors proliferation and negatively correlates to immune infiltration. | Bioengineered | 2021 | 34882061 | PubTator, text mining | PubMed |
| Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges. | Front Cell Dev Biol | 2021 | 34869376 | PubTator, text mining | PubMed |
| Detection of Antibodies Against the SARS-CoV-2 Spike Protein and Analysis of the Peripheral Blood Mononuclear Cell Transcriptomic Profile, 15 Years After Recovery From SARS. | Front Cell Infect Microbiol | 2021 | 34869070 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Immune and Prognostic Implication of MMP14 in Lung Cancer. | Dis Markers | 2021 | 34868395 | PubTator, text mining | PubMed |
| DNASE1L3 as a Novel Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma Based on Data Mining. | Front Genet | 2021 | 34868195 | PubTator, text mining | PubMed |
| Monogenic Adult-Onset Inborn Errors of Immunity. | Front Immunol | 2021 | 34867986 | PubTator, text mining | PubMed |
| Acute and Chronic Changes in Gene Expression After CMV DNAemia in Kidney Transplant Recipients. | Front Immunol | 2021 | 34867983 | PubTator, text mining | PubMed |
| Genetically Modified T Cells for Esophageal Cancer Therapy: A Promising Clinical Application. | Front Oncol | 2021 | 34858843 | PubTator, text mining | PubMed |
| A Transcriptional Signature of IL-2 Expanded Natural Killer Cells Predicts More Favorable Prognosis in Bladder Cancer. | Front Immunol | 2021 | 34858395 | PubTator, text mining | PubMed |
| Use of Induced Pluripotent Stem Cells to Build Isogenic Systems and Investigate Type 1 Diabetes. | Front Endocrinol (Lausanne) | 2021 | 34858326 | PubTator, text mining | PubMed |
Minimum redundancy maximal relevance gene selection of apoptosis pathway genes in peripheral blood mononuclear cells of HIV-infected patients with antiretroviral therapy-associated mitochondrial toxicity. | BMC Med Genomics | 2021 | 34852799 | PubTator, text mining | PubMed |
| T cell landscape and dynamics in immunoglobulin light chain amyloidosis before and after daratumumab-based therapy. | Clin Transl Med | 2021 | 34845849 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=87